Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
THERAVANCE BIOPHARMA INC
Ticker: TBPH
CUSIP: G8807B106
Class: Common Stock
Crewe Advisors LLC's Holding History (CIK: 0001730033)
Note: Option positions (PUT/CALL) are excluded.
Q3 2022
Shares
131
Value ($000)
$1
Avg Close
$9.37
Range
$7.53 - $11.00
Q2 2022
Shares
131
Value ($000)
$1
Avg Close
$9.21
Range
$8.15 - $10.52
Period
Shares
Value ($000)
Average Close
Price Range
Q3 2022
131
$1
$9.37
$7.53 - $11.00
Q2 2022
131
$1
$9.21
$8.15 - $10.52